FDA Sees More Breakthrough Drugs, Woodcock Says

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Feb. 11 (Bloomberg) -- Janet Woodcock, director of the Food and Drug Administration's Center for Drug Evaluation and Research, talks about the FDA's efforts to speed drugs to market and policies on generic and bio-similar treatments. Woodcock, speaking at Bloomberg's "State of Health Care 2013" summit in New York, also comments on drug shortages. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change